Literature DB >> 18468444

Inhibitors of tubulin polymerization: synthesis and biological evaluation of hybrids of vindoline, anhydrovinblastine and vinorelbine with thiocolchicine, podophyllotoxin and baccatin III.

Daniele Passarella1, Alessandra Giardini, Bruno Peretto, Gabriele Fontana, Alessandro Sacchetti, Alessandra Silvani, Cristina Ronchi, Graziella Cappelletti, Daniele Cartelli, Jurgen Borlak, Bruno Danieli.   

Abstract

A series of novel hybrid compounds obtained by the attachment of anhydrovinblastine, vinorelbine, and vindoline to thiocolchicine, podophyllotoxin, and baccatin III are described. Two types of diacyl spacers are introduced. The influence of the hybrid compounds on tubulin polymerization is reported. The results highlight the importance of the length of the spacer. Immunofluorescence microscopy and flow cytometry measurements that compound with the best in vitro activity could disrupt microtubule networks in cell and prevent the formation of the proper spindle apparatus, thereby causing cell cycle arrest in the G2/M phase. The newly synthesized compounds were tested in the human lung cancer cell line A549.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468444     DOI: 10.1016/j.bmc.2008.04.025

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

1.  Ferrocenyl 2,5-Piperazinediones as Tubulin-Binding Organometallic ABCB1 and ABCG2 Inhibitors Active against MDR Cells.

Authors:  Anna Wieczorek; Andrzej Błauż; Janusz Zakrzewski; Błażej Rychlik; Damian Plażuk
Journal:  ACS Med Chem Lett       Date:  2016-02-22       Impact factor: 4.345

Review 2.  Measurement of ligand binding to tubulin by sulfhydryl reactivity.

Authors:  Adrian Begaye; Dan L Sackett
Journal:  Methods Cell Biol       Date:  2010       Impact factor: 1.441

3.  Catharanthine C16 substituent effects on the biomimetic coupling with vindoline: preparation and evaluation of a key series of vinblastine analogues.

Authors:  Annie Tam; Hiroaki Gotoh; William M Robertson; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-09-19       Impact factor: 2.823

4.  Total synthesis and evaluation of a key series of C5-substituted vinblastine derivatives.

Authors:  Porino Va; Erica L Campbell; William M Robertson; Dale L Boger
Journal:  J Am Chem Soc       Date:  2010-06-23       Impact factor: 15.419

Review 5.  Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.

Authors:  Ying-Qian Liu; Jing Tian; Keduo Qian; Xiao-Bo Zhao; Susan L Morris-Natschke; Liu Yang; Xiang Nan; Xuan Tian; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2014-05-14       Impact factor: 12.944

6.  7-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.

Authors:  Joanna Kurek; Patrycja Kwaśniewska-Sip; Krzysztof Myszkowski; Grzegorz Cofta; Marek Murias; Piotr Barczyński; Beata Jasiewicz; Rafał Kurczab
Journal:  Medchemcomm       Date:  2018-08-16       Impact factor: 3.597

7.  A Novel Microtubule-Disrupting Agent Induces Endoplasmic Reticular Stress-Mediated Cell Death in Human Hepatocellular Carcinoma Cells.

Authors:  Chun-Te Ho; Yu-Jia Chang; Li-Xi Yang; Po-Li Wei; Tsan-Zon Liu; Jun-Jen Liu
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

8.  Development of BODIPY FL vindoline as a novel and high-affinity pregnane X receptor fluorescent probe.

Authors:  Wenwei Lin; Jiuyu Liu; Cynthia Jeffries; Lei Yang; Yan Lu; Richard E Lee; Taosheng Chen
Journal:  Bioconjug Chem       Date:  2014-08-18       Impact factor: 4.774

Review 9.  Modifications on the basic skeletons of vinblastine and vincristine.

Authors:  Péter Keglevich; László Hazai; György Kalaus; Csaba Szántay
Journal:  Molecules       Date:  2012-05-18       Impact factor: 4.411

Review 10.  Dicarboxylic esters: Useful tools for the biocatalyzed synthesis of hybrid compounds and polymers.

Authors:  Ivan Bassanini; Karl Hult; Sergio Riva
Journal:  Beilstein J Org Chem       Date:  2015-09-09       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.